C19orf38
gene geneOn this page
Also known as HIDE1
Summary
C19orf38 (chromosome 19 open reading frame 38, HGNC:34073) is a protein-coding gene on chromosome 19p13.2, encoding Protein HIDE1 (A8MVS5).
Predicted to be located in membrane.
Source: NCBI Gene 255809 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001136482
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34073 |
| Approved symbol | C19orf38 |
| Name | chromosome 19 open reading frame 38 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HIDE1 |
| Ensembl gene | ENSG00000214212 |
| Ensembl biotype | protein_coding |
| Entrez | 255809 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 retained_intron
ENST00000397820, ENST00000587494, ENST00000592854, ENST00000872348, ENST00000872349, ENST00000872350, ENST00000872351
RefSeq mRNA: 1 — MANE Select: NM_001136482
NM_001136482
CCDS: CCDS45970
Canonical transcript exons
ENST00000397820 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001530359 | 10869218 | 10869790 |
| ENSE00001530369 | 10863170 | 10863207 |
| ENSE00001530374 | 10859915 | 10859958 |
| ENSE00002861188 | 10848415 | 10848539 |
| ENSE00003470462 | 10856265 | 10856357 |
| ENSE00003651080 | 10858316 | 10858343 |
| ENSE00003679756 | 10850259 | 10850567 |
Expression profiles
Bgee: expression breadth ubiquitous, 132 present calls, max score 98.20.
FANTOM5 (CAGE): breadth broad, TPM avg 10.5461 / max 435.6493, expressed in 536 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173859 | 9.6339 | 445 |
| 173860 | 0.6738 | 182 |
| 173858 | 0.2384 | 89 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 98.20 | gold quality |
| leukocyte | CL:0000738 | 98.11 | gold quality |
| granulocyte | CL:0000094 | 97.65 | gold quality |
| blood | UBERON:0000178 | 97.05 | gold quality |
| bone marrow | UBERON:0002371 | 93.41 | gold quality |
| bone marrow cell | CL:0002092 | 91.48 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.53 | gold quality |
| spleen | UBERON:0002106 | 85.04 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.28 | gold quality |
| vermiform appendix | UBERON:0001154 | 80.92 | gold quality |
| right testis | UBERON:0004534 | 78.83 | gold quality |
| testis | UBERON:0000473 | 77.99 | gold quality |
| left testis | UBERON:0004533 | 77.81 | gold quality |
| right lung | UBERON:0002167 | 75.72 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 73.37 | gold quality |
| lymph node | UBERON:0000029 | 72.94 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 72.86 | gold quality |
| lung | UBERON:0002048 | 70.64 | gold quality |
| placenta | UBERON:0001987 | 70.62 | gold quality |
| gall bladder | UBERON:0002110 | 70.05 | gold quality |
| gastrocnemius | UBERON:0001388 | 69.71 | gold quality |
| muscle of leg | UBERON:0001383 | 69.09 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.42 | gold quality |
| substantia nigra | UBERON:0002038 | 68.31 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 66.63 | gold quality |
| left uterine tube | UBERON:0001303 | 66.02 | gold quality |
| fallopian tube | UBERON:0003889 | 65.87 | gold quality |
| muscle tissue | UBERON:0002385 | 65.54 | gold quality |
| omental fat pad | UBERON:0010414 | 65.46 | gold quality |
| right lobe of liver | UBERON:0001114 | 65.34 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 24.75 |
| E-ANND-3 | yes | 10.25 |
| E-MTAB-9801 | yes | 6.63 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting C19orf38, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-670-5P | 99.67 | 69.94 | 1565 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-4324 | 99.04 | 70.14 | 1569 |
| HSA-MIR-6780A-3P | 98.42 | 67.49 | 1518 |
| HSA-MIR-615-5P | 98.10 | 63.76 | 591 |
| HSA-MIR-637 | 97.91 | 64.05 | 1517 |
| HSA-MIR-4732-3P | 97.15 | 65.45 | 881 |
| HSA-MIR-4288 | 97.11 | 67.23 | 1636 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | AB124611 | ENSMUSG00000057191 |
| rattus_norvegicus | C8h19orf38 | ENSRNOG00000033256 |
Protein
Protein identifiers
Protein HIDE1 — A8MVS5 (reviewed: A8MVS5)
All UniProt accessions (1): A8MVS5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_001129954* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR040438 | HIDE1 | Family |
| IPR041066 | C19orf38_Ig | Domain |
Pfam: PF17737
UniProt features (9 total): topological domain 2, glycosylation site 2, signal peptide 1, chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MVS5-F1 | 73.98 | 0.40 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 48, 97
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 127 (showing top):
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, chr19p13, CHEN_METABOLIC_SYNDROM_NETWORK, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP, ARID5B_TARGET_GENES, ATF6_TARGET_GENES, BARX1_TARGET_GENES, DACH1_TARGET_GENES, DIDO1_TARGET_GENES, E2F5_TARGET_GENES, FOXD2_TARGET_GENES, HES4_TARGET_GENES, HHEX_TARGET_GENES, IRF5_TARGET_GENES, KLF7_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
56 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C19orf38 | GIMAP1 | Q8WWP7 | 380 |
| C19orf38 | ARHGEF26 | Q96DR7 | 323 |
| C19orf38 | VAMP5 | O95183 | 320 |
| C19orf38 | KANK2 | Q63ZY3 | 317 |
| C19orf38 | DOCK6 | Q96HP0 | 311 |
| C19orf38 | AMPD2 | Q01433 | 300 |
| C19orf38 | GGT5 | P36269 | 272 |
| C19orf38 | GNAI2 | P04899 | 249 |
| C19orf38 | TRIB1 | Q96RU8 | 243 |
| C19orf38 | SEMA3F | Q13275 | 210 |
| C19orf38 | SH2B3 | Q9UQQ2 | 193 |
| C19orf38 | COL4A2 | P08572 | 177 |
| C19orf38 | KCNN3 | Q9UGI6 | 176 |
| C19orf38 | VASP | P50552 | 167 |
| C19orf38 | COL4A1 | P02462 | 154 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HIDE1 | KRTAP1-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HIDE1 | GSDME | psi-mi:“MI:0914”(association) | 0.530 |
| CFTR | HIDE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| HIDE1 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| ALKBH7 | HIDE1 | psi-mi:“MI:0914”(association) | 0.350 |
| DNAJC5 | HIDE1 | psi-mi:“MI:0914”(association) | 0.350 |
| PLAAT1 | HIDE1 | psi-mi:“MI:0914”(association) | 0.350 |
| TTPAL | HIDE1 | psi-mi:“MI:0914”(association) | 0.350 |
| LCN2 | HIDE1 | psi-mi:“MI:0914”(association) | 0.350 |
| HIDE1 | KRTAP1-1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (83): C19orf38 (Two-hybrid), TNPO2 (Affinity Capture-MS), PDS5A (Affinity Capture-MS), GPRC5B (Affinity Capture-MS), RRP1 (Affinity Capture-MS), DYNC2H1 (Affinity Capture-MS), NF1 (Affinity Capture-MS), LTN1 (Affinity Capture-MS), C19orf38 (Affinity Capture-MS), TNPO3 (Affinity Capture-MS), DFNA5 (Affinity Capture-MS), C19orf38 (Affinity Capture-MS), NCAPG2 (Affinity Capture-MS), HEATR3 (Affinity Capture-MS), RABGAP1L (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GW64, A0A5F4BST2, A0PJX4, A8MVS5, A8MWV9, B0FP48, E5RIL1, E9PGG2, O14836, O60320, O95998, P09564, Q01113, Q01114, Q13477, Q2KI80, Q2T9R2, Q3TS39, Q3UPR0, Q3URD2, Q4V9L6, Q5FVJ4, Q5M869, Q6A044, Q6UWJ8, Q75VT8, Q864V4, Q8BRJ3, Q8BX43, Q8C503, Q8IVY1, Q8K5A9, Q8N112, Q8NC24, Q8NDY8, Q8QZT4, Q8R138, Q969Z4, Q9BUF7, Q9CQM1
Diamond homologs: A8MVS5, Q75VT8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1521 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:10850564:CCAGG:C | donor_loss | 1.0000 |
| 19:10850565:CAGG:C | donor_loss | 1.0000 |
| 19:10850566:AGGTA:A | donor_loss | 1.0000 |
| 19:10850568:GTAAG:G | donor_loss | 1.0000 |
| 19:10850569:T:A | donor_loss | 1.0000 |
| 19:10856251:T:TA | acceptor_gain | 1.0000 |
| 19:10856263:A:AG | acceptor_gain | 1.0000 |
| 19:10856264:G:GA | acceptor_gain | 1.0000 |
| 19:10863205:GCG:G | donor_gain | 1.0000 |
| 19:10863208:G:GG | donor_gain | 1.0000 |
| 19:10869206:A:AG | acceptor_gain | 1.0000 |
| 19:10869206:ACAT:A | acceptor_gain | 1.0000 |
| 19:10869206:ACATG:A | acceptor_gain | 1.0000 |
| 19:10869208:A:AG | acceptor_gain | 1.0000 |
| 19:10869208:AT:A | acceptor_gain | 1.0000 |
| 19:10869208:ATG:A | acceptor_gain | 1.0000 |
| 19:10869209:T:G | acceptor_gain | 1.0000 |
| 19:10869209:T:TA | acceptor_gain | 1.0000 |
| 19:10869210:G:A | acceptor_gain | 1.0000 |
| 19:10836771:G:GG | donor_gain | 0.9900 |
| 19:10848430:T:TA | acceptor_gain | 0.9900 |
| 19:10848536:GCTG:G | donor_gain | 0.9900 |
| 19:10850254:TGCA:T | acceptor_loss | 0.9900 |
| 19:10850255:GCA:G | acceptor_loss | 0.9900 |
| 19:10850256:CAGGC:C | acceptor_loss | 0.9900 |
| 19:10850257:A:AG | acceptor_gain | 0.9900 |
| 19:10850257:A:G | acceptor_loss | 0.9900 |
| 19:10850258:G:GG | acceptor_gain | 0.9900 |
| 19:10856264:GT:G | acceptor_gain | 0.9900 |
| 19:10858314:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
1487 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:10850372:T:C | F49L | 0.996 |
| 19:10850374:C:A | F49L | 0.996 |
| 19:10850374:C:G | F49L | 0.996 |
| 19:10850442:T:C | F72S | 0.995 |
| 19:10850373:T:C | F49S | 0.994 |
| 19:10850339:T:A | C38S | 0.993 |
| 19:10850340:G:C | C38S | 0.993 |
| 19:10850441:T:C | F72L | 0.993 |
| 19:10850443:T:A | F72L | 0.993 |
| 19:10850443:T:G | F72L | 0.993 |
| 19:10850489:T:A | C88S | 0.993 |
| 19:10850490:G:C | C88S | 0.993 |
| 19:10850373:T:G | F49C | 0.992 |
| 19:10850442:T:G | F72C | 0.992 |
| 19:10850339:T:C | C38R | 0.991 |
| 19:10850340:G:A | C38Y | 0.991 |
| 19:10850341:C:G | C38W | 0.989 |
| 19:10850334:T:A | I36N | 0.987 |
| 19:10856294:A:C | S124R | 0.987 |
| 19:10856296:C:A | S124R | 0.987 |
| 19:10856296:C:G | S124R | 0.987 |
| 19:10850540:A:C | S105R | 0.986 |
| 19:10850542:C:A | S105R | 0.986 |
| 19:10850542:C:G | S105R | 0.986 |
| 19:10869341:T:C | F223L | 0.986 |
| 19:10869343:C:A | F223L | 0.986 |
| 19:10869343:C:G | F223L | 0.986 |
| 19:10850379:T:A | L51Q | 0.985 |
| 19:10850489:T:C | C88R | 0.984 |
| 19:10850490:G:A | C88Y | 0.984 |
dbSNP variants (sampled 300 via entrez): RS1000004983 (19:10841966 A>G), RS1000066619 (19:10843273 T>C), RS1000223483 (19:10838873 C>G), RS1000271041 (19:10853048 A>C), RS1000446867 (19:10846181 CAAA>C,CAA,CAAAA), RS1000460221 (19:10858934 ATGT>A), RS1000480887 (19:10845151 C>A,T), RS1000486946 (19:10851652 G>A,T), RS1000665260 (19:10843838 G>A), RS1000747461 (19:10851307 C>A), RS1000754726 (19:10851830 C>T), RS1000760892 (19:10857509 G>T), RS1000793611 (19:10857777 A>T), RS1000834999 (19:10856755 C>T), RS1000946819 (19:10864164 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, affects methylation | 2 |
| Cisplatin | affects cotreatment, decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| aminomethylphosphonic acid (AMPA) | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Testosterone | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| 2,4-Dichlorophenoxyacetic Acid | increases expression | 1 |
| Asbestos, Serpentine | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.